Code | 8958D | ||||||||||
MA number | 16/0281/21-S | ||||||||||
Product Form: | tbl flm 14x2,5 mg (blis.PVC/PVDC/PVC/priehľ.fólia//Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | KRKA, d.d., Novo mesto, Slovenia | ||||||||||
Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 18.11.2021 |
Validity: | 18.11.2026 |
SPC: | SPC_Aboxoma_2,5 mg_tbl flm_10.2022.pdf |
PIL: | PIL_Aboxoma_2,5 mg_tbl flm_10.2022.pdf |
Safety feature | Yes |
Data update: | 23.11.2021 |